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During embryonic development multiple waves of hematopoietic progenitors with distinct
lineage potential are differentially regulated in time and space. Consistent with this view,
some specialized lymphocytes emerge during a limited time-window in embryogenesis
and migrate to the tissues where they contribute to organogenesis and to tissue homeo-
stasis. These cells are not constantly produced by bone marrow derived hematopoietic
stem cells but are maintained in tissues and self-renew throughout life. These particular
cell subsets are produced from lymphoid restricted progenitors only found in the first days
of fetal liver hematopoietic activity. Growing evidence of the heterogeneity and layered
organization of the hematopoietic system is leading to a common view that some
lymphocyte subsets are functionally different because they follow distinct developmental
programs and emerge from distinct waves of lymphoid progenitors. However, under-
standing the influence of developmental origin and the relative contribution of local
microenvironment on the development of these specialized lymphocyte subsets needs
further analysis. In this review, we discuss how different pathways followed by developing
B cells during ontogeny may contribute to the diverse functions.Circulating blood cells are continuously produced from bone
marrow (BM)-derived hematopoietic stem cells (HSCs), how-
ever, recent studies have challenged this view by establishing
an exclusive embryonic origin of some tissue resident im-
mune cells that persist throughout life [1e4]. These cells that
comprise B-1 B, some subsets of gd T and lymphoid tissue
inducer (LTi) cells are capable of self-renewing and respond tosis, Immunology Departm
umano).
g Gung University.
ublishing services by Else
s/by-nc-nd/4.0/).changes in tissue environment [4]. In addition, they contribute
to tissue homoeostasis and represent the first line of defense
against pathogens [2,4,5]. The layered immune system hy-
pothesis was first introduced by Herzenberg and Herzenberg
[6] to highlight the unique fetal origin of some hematopoietic
cell populations correlated with a more primitive phyloge-
netic origin. Recent advances in lineage tracing and cellularent, Institut Pasteur, U1223, INSERM, 75724, Paris, France.
vier B.V. This is an open access article under the CC BY-NC-ND
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force the idea of a multi-layered immune system. Growing
evidence is linking immune cell heterogeneity in homeostasis
to their developmental origin during ontogeny, although the
relative contribution of origin or of environmental signals to
function is still under investigation. One clear example of
embryonic origin and HSC-independency is the microglia and
other tissue resident macrophages [7] shown by Perdiguero
et al. to be derived from yolk sac (YS) erythro-myeloid pro-
genitors (EMP). Whether the origin rather than the immediate
location of tissue resident macrophages modulate their
diverse functions and what are the differences in gene
expression inherent to YS-derived macrophages are issues
that remain to be resolved. In line with the view that the im-
mune system is composed of cells that are generated in suc-
cessive waves, some specialized lymphocytes produced
during embryogenesis are tissue resident cells and share
innate-like properties such as rapid response to antigen
stimulation and contribution to tissue homeostasis [2]. The
origin of these lymphocytes remain controversial as they have
been suggested to emerge before definitive HSCs are detected
[8,9]. So, similar to tissue residentmacrophages, innate-like B-
1a cells, Vg5þ or Vd1þ IL-17þ gd T cells or LTi could derive from
hematopoietic progenitors independent from HSC [10]. Here
we discuss how developmental origins and local tissue signals
may contribute to the multi-layered developmental programs
of lymphocyte subsets during ontogeny.HSC-independent lymphopoiesis
Fetal hematopoiesis occurs in distinct waves starting with a
primitive wave from the YS which gives rise to nucleated
erythrocytes and megakaryocytes [11]. Around embryonic
day 8 (E8) the blood circulation is established [12] and the YSFig. 1 Emergence of waves of hematopoietic progenitors in themo
progenitors; AGM: aorta, gonads and mesonephros; HSC: hematoharbors multipotent erythro-myeloid progenitors (EMPs),
which lack long term reconstitution capacity and showed
recently to be the origin of tissue resident macrophages and
mast cells [Fig. 1] [7,13e15]. One day later, around E9.5, the
pre-HSCs emerge in the major arteries [16,17] through an
endothelial to hematopoietic transition mechanism (EHT)
[18e20], show multipotency in vitro but do not reconstitute
hematopoiesis in vivo [17]. Only after maturation in an organ
culture system can they behave like their adult BM counter-
parts. Consistent with these observations, fate mapping
studies showed that pre-HSCs labeled between E9.5 and E10.5
are the main source of adult HSC in the BM [21e23] and de
novo production of HSC is no longer detected after E10.5. Thus
at E10.5 the fetal liver (FL), the main hematopoietic organ
during embryonic development, harbors highly proliferative
multipotent progenitors of dual origin derived from both pre-
HSCs generated in the major arterial vessels and from EMP
generated in the YS [24]. This tight sequence of events and the
dual source of blood cell generation raise the possibility that
distinct lymphoid progenitors may exist before the emer-
gence of HSC. Using Ncx1/ mice, which lack heartbeat,
Yoshimoto et al. showed that E9.5 YS harbors T-cell, B-1 cell
and MZ B-cell progenitors suggesting that they originate in
situ. However, while Ncx1/mice die at E11 both YS-derived
and HSC-derived progenitors emerge normally [25]. Consid-
ering that pre-HSCs emerge from the dorsal aorta but also
from the vitellin and umbilical arteries [26,27] that connect
the embryo proper to the YS arterial vessels, it is likely that
the lymphoid progenitors found in the YS correspond to
emerging pre or immature HSC. In a different approach,
Kobayashi et al. used HSC-deficient embryos to probe the
origin of B and T cells in the mouse embryo [28]. Cbfb /mice
are not viable after E13 and have severe defects in EMPs and
HSCs because the function of all Runx genes is compromised
[29]. When endothelial-specific receptor tyrosine kinase (Tek)use embryo. Abbreviations: YS: yolk sac; EMP: erythromyeloid
poietic stem cells; BM: bone marrow.
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cells were restored but not HSC. However, low numbers of
LSK cells were detected possibly accounting for the B and T
found in these mice although long-term reconstitution was
severely compromised.
Combining reporter mouse lines with lineage tracing,
Boiers et al. identified a population of progenitors contributing
to fetal lymphocytes and myeloid cells (though not tissue
resident macrophages), with no contribution to erythrocytes
or megakaryocytes [8]. This lymphomyeloid (LMPs) restricted
progenitors were further shown to co-express lymphoid and
myeloid-associated genes (Il7r, Rag1, Rag2, Flk2, Csf1r, Csf2r
and Csf3r). That they preceded long-term reconstitution abil-
ity was used as argument to their HSC independence and
potential YS origin. However, the lineage potential of these
progenitors at early developmental stages has not been thor-
oughly addressed and, as we previously mentioned, although
long term reconstitution is detected at low levels before E12.5
the immature or pre-HSC emerge between E9.5 and E10.5, are
highly proliferative and can progress to differentiate before
acquiring adult reconstitution capacity.
In conclusion it is now established that the B cell
compartment is composed of cells that develop in successive
waves differentially regulated in time and space, the contri-
bution of the YS-derived progenitors to lymphopoiesis re-
mains controversial and further studies are required to show
to what extent, if at all, HSC-independent progenitors
contribute to the lymphoid compartment.Early B cell differentiation and commitment
Lymphocyte homeostasis is dependent on the constant pro-
duction of B cells from HSC-derived progenitors in the bone
marrow. However, whereas follicular B cells are profoundly
affected when BM B cell production is interrupted, marginal
zone and B-1 B cells are minimally affected. These results
suggest that B-1 B cells and marginal zone B cells are prefer-
entially produced early in life.
B-1a cell development during embryogenesis
Unlike adult HSCs, fetal HSCs are highly proliferative in FL and
are unique in their capacity to generate innate-like lympho-
cyte subsets [30,31]. Why are innate-like lymphocytes only
produced by fetal HSCs? And to what extent are develop-
mental timing and signals from the microenvironment
orchestrating this process? Tissue resident B-1a cells are
found in the peritoneal and pleural cavities, they are the main
producers of natural IgM antibodies and respond to bacterial
products in a T-independent manner [32]. B-1a cell generation
decreases after birth and the B-1a cell compartment is sus-
tained by self-renewal independent of adult HSCs input, un-
like B-2 B cells that need continuous replenishment fromadult
HSCs [33]. Although it was shown that B-1a cells can also be
produced from BM HSCs, it is consensual that FL hematopoi-
etic progenitors are more efficient than their BM counterparts
in the generation of this cell subset [34]. In order to identify
which cells in FL are capable of generating B-1a cells, Ghosn
et al. purified E15 FL LSK [35] that failed to generate B-1a cells.These data suggest that B-1a could be a distinct lineage in-
dependent of fetal HSCs, although, differences in the gating
strategy for identifying HSCsmight result in differences in the
cellular output (reviewed in Beaudin et al., 2016) [36]. Moreover
fetal HSCs are CD11bþ, and somemight have been eliminated
due to the presence of anti-CD11b antibody in the lineage
cocktail [31,36].
Following similar line of research data from the Forsberg
laboratory [37] used a Flk-Switch mouse model to define two
distinct populations of fetal HSCs. The authors identified a
developmentally restricted Flk2 dependent HSCs population
with apparent long-term reconstituting capacity particularly
efficient in generating B-1 cells that ceased to persist after
birth [38]. These cells are different from adult HSCs in their
bias to generate lymphoid cells particularly innate-like B-1a
and Vg5þ T cells and express lymphoid-associated genes (Il7r,
Rag1, Flk2, Rag2 and Ccr9). This work raised the possibility of
the existence of distinct fetal HSC lineages and again
providing evidence that B-1a cells might be derived from
progenitors distinct from those generating other B cell sub-
sets. In this study however, the transient nature of these
progenitors and their expression of lymphoid specific tran-
scripts do not coincide with the generally accepted definition
of HSC [39]. Therefore, further investigations are required to
clarify the extent to which these cells differ from the lympho-
myeloid primed progenitors (LMPP).
In line with these data, a recent report from Dorshkind
laboratory supported that B-1a cells emerge from multiple
waves of fetal progenitors [40]. The analysis of a PU.1 hypo-
morphic mouse model (URED/D) showed that both B-1 and B-2 B
cells are differentially sensitive to different levels of PU.1
expression depending on whether they were generated from
early or later embryonic stages, further reinforcing the idea that
fetal and adult B cells followdifferent developmental programs.
Following a different strategy, cellular barcoding was used
to label fetal HSCs and evaluate heterogeneity in fetal B cell
production [41]. It was shown that unlike some previously
mentioned studies fetal HSC generate upon transfer both B-1
and B-2 cells and the same barcodes are shared between B-1,
B-2 and HSCs indicating their common origin. Interestingly,
secondary transplantation of sorted LSK cells from a recipient
of barcoded fetal LSK exhibited a lower B-1a potential
compared to primary recipients. These data indicated that
fetal HSC progressively lose the capacity to generate B-1 cells
upon transfer and this coincided with the downregulation of
Lin28b, a negative regulator of the let-7 family of microRNA
expressed in fetal but not adult HSCs [42]. Consistent with this
observation, Lin28b overexpression in BM HSCs restored the
capacity to generate fetal lymphopoiesis (though not Vg5þ T
cells) including B-1a cells providing evidence that Lin28b is a
key modulator of B-1 cell production. In line with this study,
in vivo barcoding experiments in the absence of trans-
plantation found similar barcodes expressed in adult B-1 and
B-2 cells indicting that HSC do generate both B cell compart-
ments [23]. Furthermore, work from the Rajewsky laboratory
showed that switching specificities of mature B cells from a B-
2 to a B-1 B-cell receptor is sufficient to induce cell prolifera-
tion and acquisition of the B-1 phenotype and function.
Altogether these latter experiments argue against a distinct
HSC-independent origin of B-1 lymphocytes [43]. The role of
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identified, as the B-2 to B-1 lineage transition induced by B cell
receptor switch appears to be Lin28b independent.Key transcriptional regulators of B-cell lineage
Lineage priming and commitment during hematopoiesis is a
stepwise process starting in HSCs. During lymphoid specifica-
tion, CLPs derived from HSC express the IL7Ra which is a hall-
mark of lymphoid commitment [44]. This lineage commitment
process is achieved through differential expression of lineage
specific transcription factors such as Pu.1, Ikaros, E2a, Ebf1 and
Pax5.Wewill review the role of these key transcriptional factors
in the establishment of B-cell identity [Fig. 2].
PU.1
Pu.1 is an ETS-domain transcription factor encoded by the Spi-1
gene that is exclusively expressed in hematopoietic cells dur-
ing ontogeny [45,46]. Pu.1 acts by binding to a purine-rich
sequence (PU-box) near the promoter region of target genes.
PU.1 deficient mice die around embryonic day E18 and lack
both B cells and myeloid cells in the FL [46]. Of note, HSC [47],
lympho-myeloid progenitors (AA4.1þ, Lin) [48], aswell as CLPs
and early B cell precursors (IL7RþKitþ) are dramatically reduced
in PU.1 deficient embryos. In vitro cultures of any of these
progenitors showed reduced capacity to differentiate into B or
myeloid cells, indicating that Pu-1 acts at different stages of
hematopoietic differentiation. Conditional deletion of Pu.1 in
CD19-expressing B cells resulted in an increased compartment
of cells resembling B-1 cells while B-2 cells were compromised.
This imbalanced of B-1/B-2 cell development indicated a role of
Pu.1 in B-2/B-1 cell reprograming [49] and is consistent with its
role in the development of different B cell subsets [40].
Ikaros
Ikaros belongs to the family of zinc finger transcription fac-
tors, widely expressed in hematopoietic cells and one of
the key regulators of hematopoiesis. In lymphoid lineage
development, Ikaros deficient mice showed impaired B, T andFig. 2 Major transcriptional requiremeNK cell production, while the myeloid and erythroid lineages
were not significantly affected [50]. Similar deficiency of B, T,
and NK compartments was observed in an Ikaros null mouse
model in which the DNA binding site was deleted [51].
Ikaros regulates different aspects of B cell specification,
development, maturation and response. Ikaros null LMPPs
failed to express the lymphoid-associated transcripts Il7ra and
Flt3, that are critical for early B lineage specification from
lymphoid progenitors [51]. Ikaros also induced Ebf1 expression,
which in turn promoted B cell differentiation by activating the
B cell transcriptional program, and over expression of Ebf1 but
not of Il7ra or Flt3 in Ikaros/ LSK cells rescued B cell potential
[52]. However, these rescued B lineage cells failed to recom-
bine Igh locus demonstrating that Ikaros also activates Rag
gene expression and controls VH gene accessibility [52].
During B cell responses in the periphery, Ikaros regulates B
cell activation threshold [53], and antibody isotype selection
via Ig class switch recombination (CSR). Ikaros deficient B cells
showed higher sensitivity to anti-IgM stimulation and Ikaros
regulates class switch recombination (CSR) by activating
epigenetic marks and transcription at constant region gene
promoters. Ikaros mutant mice exhibit reduction in serum
IgG3 and IgG1, and increased in IgG2b and IgG2 production
[53]. Ikaros binds the 3’ enhancer and S region promoters of
Igh locus to increase AID accessibility to Sg2b and Sg2a to
induce AID dependent CSR to IgG2b and IgG2a. Thus, Ikaros is
a crucial regulator of CSR through modulating transcriptional
competition between S regions.
E2A
The transcription factor E2a regulates gene expression by
binding to the E box domain of DNA [54] and belongs to the
helix-loop-helix (HLH) protein family. E2a is required for
lymphopoiesis in regulating both B and T cell development.
Further differentiation from CLP to B lineage is dependent on
the successive expression of the transcriptional factors E2a,
Ebf1, and Pax5 [55].
B cell development in E2A-deficient mice is arrested at the
very early Pre-proB cell stage [56e58]. In the absence of E2a,
lymphoid progenitors failed to express B lineage-associated
genes, such as Rag1, Pax5, CD19, CD79a (mb1) and l5, innts for lymphocyte development.
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expression of E2a in E2A-deficient progenitors can restore Ebf1
expression by binding and activating the promoter of Ebf1
[59e61]. Forced retroviral expression of Ebf1 in E2A-deficient
progenitors restores their capacity to generate proB cells
in vitro cultures, with normal V(D)J recombination at the IgH
locus and normal expression of B-lymphoid-associated genes
[62]. Altogether, these data indicate that E2a acts upstream of
Ebf1 and Pax5 in the initiation of the B lineage differentiation
program [56,63].
Id2 that blocks E box protein function inhibits the T and B
developmental programs restricting Id2 expressing CLP to the
innate lymphoid differentiation pathway.
Ebf1
Ebf1 (Early B cell factor 1) is exclusively expressed in B lineage
cells and has a regulatory role in the earliest stages of B cell
specification and development [64]. Mice deficient in Ebf1 fail
to express B lineage specific genes, such as Pax5, mb-1, sur-
rogate light chain l5 and VpreB [45,64,65]. B cell development
in Ebf1/ mice was blocked at Pre-proB stage and no heavy
chain rearrangements were detected. This phenotype is
similar to that found in E2A deficient mice, suggesting these
two factors orchestrate B cell development. However, Ebf1
inactivation exclusively affects B cell development. This
observation indicates that the transcription factors PU.1,
Ikaros, and E2A, are expressed prior to Ebf1.
Ebf1 overexpression can launch the B cell program in pro-
genitors deficient in upstream transcription factors, including
PU.1 and E2A. Ectopic Ebf1 expression in E2A/ [62], PU.1/
[66], IL-7/ [67,68] mice can to some extend restore B cell
development. Ebf1 is expressed in CLPs and coincides with B
lineage restriction in Ly6DþIl7Rþ CLPs [69], a stage at which
most B cell specific genes are not expressed. Expression of Ebf1
in these cells is sufficient to activate a B lineage transcrip-
tional network, comprising Pax5 [70] and silencing genes
involved in T and NK cell development. Conditional deletion
of Ebf1 in committed pro-B cells generated innate lymphoid
cell (ILCs) and T cells after transfer into alymphoid mice.
However, the T cells derived from Ebf1-deficient pro-B cells
had rearrangements of loci encoding both B cell and T cell
antigen receptors [71]. Thus, Ebf1 is required for B lineage
commitment by blocking alternative cell fates.
Conditional deletion of Ebf1 at later B cell developmental
stages did not result in major differences in the expression
of a number of Ebf1 target genes, such as Pax5, mb-1 and
CD79b [72].
Pax5
Pax5, also called B cell lineage specific activator protein (BSAP),
is a member of a paired box family 5. Pax5 is exclusively
expressed in B cells, starting at the pro-B cell stage [73]. One of
the important roles of Pax5 is the regulation of CD19 expres-
sion. Deficiency of Pax5 arrests B cell development at a stage
before pro-B stage in both fetal and adult cells [74].
Ebf1/ deficient B cell progenitors cannot be rescued
by Pax5 over-expression [66], suggesting that Pax5 acts
downstream of E2a and Ebf1 in the transcriptional network ofearly B cell development [74]. In vitro cultures of Pax5/ pro-
genitors in the presence of IL-7 generated proB-like cells that
further differentiated into macrophages, granulocytes, den-
dritic cells, or natural killer cells when IL-7 was withdrawn.
In vivo in Rag/ mice and in vitro co-culture with OP9-DL1
stromal Pax5/ pro-B progenitor generated T cells [74]. These
studies showed that Pax5 is critical to restrict the differentia-
tion to B lineage pathway and inhibit alternative pathways.
B-cell lineage commitment: timing for lineage choice
B cell development is one of the best studied differentiation
processes orchestrated by known transcription factors that
are activated early in B cell development and sustain their
activity throughout the life of a B-cell [45]. Immune cells are
produced from multipotent and self-renewing HSCs that give
rise to multipotent progenitors (MPP). In the bone marrow, B
cells develop from HSCs through a series of stepwise restric-
tion towards the B cell lineage. Long-term (LT) HSCs give rise
to short-term (ST) HSCs that expand and produce MPPs [75].
The MPPs are capable of generating all blood lineages but lack
self-renewing capacity in transplantation experiments and
give rise to LMPPs, which are the earliest progenitor cell to
express lymphoid-associated genes (Il7r, Rag1, Rag2 and Flk2)
and maintain myeloid potential but lack megakaryocyte-
erythroid potential [21,39,76,77]. LMPPs differentiate into
common lymphoid progenitors (CLPs) that are Lin-c-Kitlo-
Sca1loIL-7Rþ [44]. These cells are different from LMPPs as they
lost their myeloid potential and give rise to plasmacytoid
dendritic cells (pDC), ILC, B and T cells [2,45]. Of note, B cell
developmental program depends on the successive upregu-
lation of E2A, EBF1 and Pax5. In order to understand the initial
stages of B lineage priming, we and others analyzed the CLP
compartment in the FL. In the FL, CLPs [78] are identified as
Lin-c-KitþSca1loIL-7Rþ and they represent a heterogenous
compartment capable of generating all lymphoid lineages
including CD3- LTi [2]. Flk2 surface expression separates fetal
CLPs into Flk2- population with restricted progenitors to B and
ILC and a Flk2þ population representing immature pro-
genitors capable of differentiating into B, T and ILC [Fig. 3]
[79,80]. Moreover, the integrin a4b7 further separate pro-
genitors that lost B cell potential and retain T and ILC potential
[81,82]. The loss of T cell potential and the restriction to ILC
is concomitant to the loss of Flk2 and the upregulation of
C-X-C motif chemokine receptor 6 (CXCR6) [82]. Therefore,
LinIL-7Raþc-KitþSca-1loFlk2þa4b7
- FL CLPs are the most
immature CLPs (iCLPs) that generate all lymphoid lineages.
In order to further understand the molecular cues that
control lineage choice before commitment, Berthault et al.
used a combination ofmarkers (Flk2, a4b7, HSA (also known as
CD24) and PIRA/B) to address this question [83]. Based on the
expression of HSA, the immature (i) CLPs (Flk2þ a4b7- IL-7Raþ)
were separated into three different populations with different
transcriptional signature and lymphocyte potential [Fig. 3].
The majority of iCLPs expressed intermediate levels of HSA
(HSAint) and retained a robust B, T and ILC potential. The two
other populations were either expressing high levels of HSA
(HSAhi) or low level of HSA (HSAlo). While HSAlo iCLPs were
biased toward T and ILC potential and had low B cell potential,
HSAhi iCLPs were biased to generate B cells with low T and ILC
Fig. 3 Lymphoid lineage choice during early stages of development in fetal liver. Abbreviations: LMPP: lympho-myeloid
progenitors; HSA: heat stable antigen; ILC: innate lymphoid cells; DC: dendritic cells.
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showed that the B cell and T cell-bias signature were initiated
at different stages of differentiation. While the transcriptional
signature that marked cells biased towards the T/ILC lineage
was detected in LMPPs, the B cell-bias signature was
concomitant with the upregulation of IL-7ra and appeared
only in CLPs. HSAint iCLPs were shown to derive from LMPPs
that further differentiated into HSAhi iCLPs and HSAlo iCLPs.
While HSAhi iCLPs expressed B-lineage associated genes (Ebf1,
Vpreb, Pax5, Foxo1, Pou2af1, Ly6d and Rag1), HSAlo iCLPs
expressed ILC-lineage associated genes (Tcf7, Gata3, Id2, Nfil3,
Rorc, Cd7, Ccr9, Pira1 and Glis3) and some transcripts found in
adult ETP (IMMGEN data base). However, they did not express
known Notch1 signaling targets that are essential for T cell
differentiation. Therefore, HSAlo iCLP although having
partially lost B cell potential do not appear to be engaged in the
T cell pathway of differentiation, only when they reach the
thymus do we find signs of Notch activation (Hes1, Dtx) [83].
This sequence of events leads to the conclusion that the
establishment of B versus T cell identity occurred at sequen-
tial stages of differentiation and it is not a binary choice, and,
importantly, the loss of B cell lineage potential may take place
before colonizing the thymus (for further discussion on this
topic, also refer to Cumano et al., 2019 [84]).Fetal hematopoietic microenvironment and
lymphoid commitment
The FL provides the unique hematopoietic environment
where in the mouse hematopoietic progenitors expand and
differentiate. Once in the FL, lymphoid progenitors initiate
differentiation and major differences between fetal and adult
hematopoiesis have been detected. For example, IL-7 is an
important cytokine for B cell development, in mice although
not in humans. Il-7-defecient mice showed a complete
absence of adult B cell development in BM and adult CLPs
were reduced in numbers and in their B cell differentiationcapacity [85]. However, fetal B cell development, although
affected, was not absent and the numbers of CLPs were
normal in the FL. These data indicated that fetal lymphopoi-
esis is partially independent of IL-7. Only when Il-7 and Flt3
deficiencies were combined, fetal lymphopoiesis were totally
absent [86]. Because the analysis of FL CLP indicated that the B
cell transcriptional program was only initiated after the
expression of the IL-7Ra chain we investigated the role of IL-7
in B cell lineage priming and commitment in FL. In Il-7-defe-
cient mice, the numbers of HSAlo iCLPs (that had lost B cell
differentiation potential) were significantly increased while
the numbers of HSAhi iCLPs (B biased) were reduced. In addi-
tion although the numbers of HSAin multipotent CLP were
normal the numbers of cells that exhibited a B cell transcrip-
tional priming was reduced compared to WT whereas the
numbers of cells with T/ILC priming were increased [83].
These experiments indicated that IL-7 plays a role in deter-
mining the numbers of B and T/ILC biased progenitors during
fetal development.
Between E12 and E15 the thymus is colonized by a first
wave of fetal thymic settling progenitors (TSPs) similar in
phenotype and function to HSAlo iCLPs and to circulating
CLPs (CRLPs). At later stages the thymus is colonized by a
second wave of LMPPs-like progenitors and FL does no longer
support the production of HSAlo iCLPs [87]. A time course
analysis showed that HSAlo iCLPs are abundant in FL be-
tween E11 and E15 and after E16 they were no longer detec-
ted. In contrast, HSAhi iCLPs were barely detected before E13
and gradually increased at later stages of development. This
progression of events coincides with an upregulation in IL-7
production as development progresses in the FL suggesting a
link between the presence of HSAlo iCLP and IL-7 availability.
Consistent with this at E11 where availability of IL-7 is low
the B lineage transcriptional signature is undetectable in IL-
7Raþ CLP. Taken together this data indicates that HSAlo iCLPs
are a transient population only found at early stages of
development and their presence is dependent on the
absence of IL-7. At later stages IL-7 secures the expression of
b i om e d i c a l j o u r n a l 4 2 ( 2 0 1 9 ) 2 0 9e2 1 7 215the B lineage transcriptional program and the thymus is
colonized thereafter by multipotent progenitors that no
longer can generate innate like lymphocytes and LTi.
Therefore after the initial stages of FL hematopoiesis the CLP
is devoted to B and ILC development and although main-
taining T cell potential in vitro these progenitors show
decreased efficiency in repopulating the T cell compartment,
in vivo [51]. These data indicate that developmental timing
and microenvironmental signals are associated with lineage
choice and explain why only during early stages unique
subsets of the immune system emerge.Perspectives
In this review we discussed the origin(s) of lymphoid pre-
cursors and how the developmental timing and microenvi-
ronmental signals may contribute to the diversity of the
immune system. It is clear that B cell development occurs in a
multi-layered unique developmental program through suc-
cessive waves of B cell progenitors. However, the origin of the
first wave of B cell progenitors and tissue resident innate-like
B-1a cells remains controversial. To determine the relative
contribution of developmental timing on B cell output, effi-
cient and faithful lineage tracing models will have to be
developed. Lineage tracing or reporter mouse models that
might be reliable and predictable during adult lymphopoiesis
might not be so during FL lymphoid development that as we
discussed above have a particular features.
The heterogeneity of fetal HSCs with respect to fetal
lymphocyte production compared to their adult counterpart
needs further investigation. Future work aimed at the func-
tional characterization of cells derived from distinct origins
will improve our understanding on how this HSC heteroge-
neity impacts on the establishment of the B cell compart-
ment. Moreover, the transcriptional regulatory networks
that govern B cell development are different in fetal and
adult lymphopoiesis. How this molecular regulation is
related to their cellular origin? And to what extent micro-
environmental signals contribute to a lineage choice?
Addressing these questions represent a major challenge in
B cell development and understanding lymphoid cell
ontogeny in general. Advances in lineage tracing and the
growing field of high-throughput single cell transcriptional
and epigenetic analysis might help in providing new insights
into how successive layers during ontogeny contribute to
different lineage output and deciphering their functional
heterogeneity.Conflicts of interest
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